Zhejiang Starry Pharmaceutical Co.,Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 517.3 million compared to CNY 364.08 million a year ago. Revenue was CNY 517.3 million compared to CNY 364.08 million a year ago. Net income was CNY 80.24 million compared to CNY 64.57 million a year ago. Basic earnings per share from continuing operations was CNY 0.2357 compared to CNY 0.1857 a year ago. Diluted earnings per share from continuing operations was CNY 0.2357 compared to CNY 0.1857 a year ago.